Back

Echocardiography and NT-ProBNP both provide independent and improved prediction of prognosis in a type 1 diabetes population without heart disease and with preserved ejection fraction

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Diabetes Diabetes and the Heart ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Magnus Thorsten Jensen

Steno Diabetes Center, Copenhagen, Herlev (Denmark)

14 More presentations in this session

Presentation thumbnail
Professor F. Schiele (Besancon, FR)
Abstract
Presentation thumbnail
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Assistant Professor B. Parapid (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Doctor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Assistant Professor A. Malik (Manchester, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Diabetes

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
NT-proBNP levels in diabetic cardiomyopathy: results from the ARISE-HF trial
20 May 2023
thumbnail
Congress Presentation
Prognostic utility of echocardiographic assessment in wild type transthyretin amyloid cardiomyopathy
22 May 2023
thumbnail
Congress Presentation
Quality of glycemic control has significant impact on myocardial mechanics in type 1 diabetes mellitus
22 May 2023
thumbnail
Congress Presentation
Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in a large general population sample
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources